NUTX Stock Analysis: Buy, Sell, or Hold?
NUTX - Nutex Health Inc. Common Stock
$126.30
-1.54 (-1.20%)
▼
5d:
-7.58%
30d:
+24.12%
90d:
+26.67%
HOLD
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: Apr 30, 2026
0d
Get Alerted When NUTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NUTX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: NUTX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$210.18
Based on 5.4% avg growth
INTRINSIC VALUE TODAY
$130.51
3.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NUTX is currently trading at $126.30, which is considered slightly high relative to its 30-day fair value range of $105.25 to $131.76. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.6) compared to its historical average (7.2). Remarkably, the market is currently pricing in an annual earnings decline of 8.0% over the next few years. This pessimistic expectation contrasts with the company's recent 95.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, NUTX is in a strong downtrend. Immediate support is located at $120.82, while resistance sits at $162.00.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $235.67 (+86.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NUTX is in a strong downtrend. Immediate support is located at $120.82, while resistance sits at $162.00.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $235.67 (+86.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$105.25 -
$131.76
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
65.2%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 86.6% below Wall St target ($235.67)
- CAUTION: Recommendation downgraded due to -7.6% 5-day decline
Trading Range Analysis
30-Day Trading Range
$105.25 -
$131.76
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$120.82
Resistance Level
$162.00
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.63
Wall Street Target
$235.67
(+86.6%)
Revenue Growth (YoY)
2.2%
Earnings Growth (YoY)
95.9%
Profit Margin
10.9%
Valuation Discount vs History
-8.0% cheaper
PE vs Historical
5.6 vs 7.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.0%
(market-implied from PE analysis)
1-Year Target
$116.20
(-8%)
2-Year Target
$106.90
(-15%)
3-Year Target
$98.35
(-22%)
3-Yr Target (if PE normalizes)
(PE: 6→7)
$125.85
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 6.8%)
$603.27
(+378%)
Base:
(SPY PE: 5.6, Growth: 6.8%)
$153.80
(+22%)
Bear:
(PE: 4.8, Growth: 6.8%)
$130.73
(+4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (9x PE), but valuation improves significantly next year (6x PE) as earnings recover.
Trailing PE: 9.10 | Current EPS (TTM): $13.68
Bull Case
$224.59
(+78%)
Analyst growth 64.1%, PE expands to 10.0
Base Case
$204.17
(+62%)
Market implied 64.1%, PE stable at 9.1
Bear Case
$84.61
(-33%)
Severe decline -20.0%, PE contracts to 7.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.6 to 7.2
Stabilization Target:
$161.62
(+28.0%)
PE Expansion Potential:
+28.0%
Share & Embed Analysis
Last updated: May 18, 2026 9:12 AM ET
Data refreshes hourly during market hours. Next update: 10:12 AM
Data refreshes hourly during market hours. Next update: 10:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NUTX showing a specific setup today?
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Frank E Jaumot
BUY
150 shares
2026-03-20
Warren Hosseinion
BUY
252 shares
2026-03-19
Kelvin Spears
BUY
10 shares
2026-03-17
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$513 | 64 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$246 | 61 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 61 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$23 | 59 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 59 HOLD |
